4//SEC Filing
Wellisch Alejandro D 4
Accession 0001415889-22-001749
CIK 0000001800other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:36 PM ET
Size
5.5 KB
Accession
0001415889-22-001749
Insider Transaction Report
Form 4
Wellisch Alejandro D
Senior Vice President
Transactions
- Award
Option (right to buy)
2022-02-18+54,280→ 54,280 totalExercise: $117.58From: 2023-02-18Exp: 2032-02-17→ Common Shares (54,280 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 18,093 on February 18, 2023, 18,093 on February 18, 2024, and 18,094 on February 18, 2025.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001717526
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:36 PM ET
- Size
- 5.5 KB